Acadia Pharmaceuticals buy Needham & Company LLC
Start price
09.04.24
/
50%
€16.56
Target price
09.04.25
€29.40
Performance (%)
-19.84%
Price
27.09.24
€14.05
Summary
This prediction is currently active. The price of Acadia Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -19.84%. This prediction currently runs until 09.04.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | 1.335% | 1.335% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by Needham___Company_LL for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $32.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Needham___Company_LL for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€13.74
07.08.24
07.08.24
€25.63
07.08.25
07.08.25
-1.06%
27.09.24
27.09.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€15.02
09.05.24
09.05.24
€27.88
09.05.25
09.05.25
-6.46%
27.09.24
27.09.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€18.20
12.03.24
12.03.24
€29.32
12.03.25
12.03.25
-22.83%
27.09.24
27.09.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.60
28.02.24
28.02.24
€33.24
28.02.25
28.02.25
-34.98%
27.09.24
27.09.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€24.80
24.01.24
24.01.24
€33.86
24.01.25
24.01.25
-46.49%
27.09.24
27.09.24